Scrip    Clinica    RAJ    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Sign me in automatically next time
scr
RAJ Pharma
US bill seeks to grant mandatory recall authority to FDA
20 July 2010
Vibha Sharma

New legislation has been introduced in the US House of Representatives that would give mandatory product recall authority to the Food and Drug Administration1,2.

The bill (HR 5740) was introduced by Edolphus Towns (Democrat – New York), chairman of the House Committee on Oversight and Government Reform, who conducted a hearing in May to examine the circumstances surrounding Johnson & Johnson's recall of children's medicines3...

Please login to read the full article.
 
Not a subscriber ?  
 
 
RELATED CONTENT
NEWS
RAJ Pharma News
Other Informa News
ANALYSIS
RAJ Pharma Analysis
Other Informa Analysis
EDITORIALS
RAJ Pharma Editorials
Other Informa Editorials
FEATURES
RAJ Pharma Features
Other Informa Features
COUNTRY PROFILES
RAJ Pharma Country Profiles
Other Informa Country Profiles
COMMENT
RAJ Pharma Comment
Other Informa Comments
EVENTS
September 15th, 2010
London, UK
September 16th, 2010
Basel, Switzerland
September 20th, 2010
London, UK
   
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36